Skip to main content

Table 3 Analytical data

From: Subclinical atherosclerosis burden in non-diabetic hypertensives treated in primary care center: the IMTABI study

 

TOTAL

n = 140 (%)

ATB (yes)

ATB (no)

p

Glycemia (mg/dL)

92 ± 11,5

92,7 ± 10,9

90,2 ± 12,5

0,2

Creatinine (mg/dL)

0,84 ± 0,1

0,88 ± 0,18

0,77 ± 0,18

0,002

Uric acid(mg/dL)

5,2 ± 1,38

5,54 ± 1,4

4,77 ± 1,17

0,001

TSH (µUI/mL)

2,1 ± 1,3

2,1 ± 1,4

2,06 ± 1,2

0,66

Ferritin (ng/mL)

132 ± 107

129,8 ± 107

137,9 ± 109

0,67

hsCRP (mg/L)

3,3 ± 3,4

3,6 ± 3,5

2,6 ± 3,2

0,12

HbA1c (%)

5,6 ± 0,3

5,6 ± 0,3

5,5 ± 0,3

0,29

Cholesterol (mg/dL)

206 ± 34

204 ± 33,5

208 ± 36,7

0,58

HDL cholesterol (mg/dL)

52 ± 12

51 ± 11

55 ± 14

0,07

 Women

57 ± 12

55 ± 10

59 ± 15

0,2

 Men

48 ± 10

49 ± 10

48 ± 9

0,8

LDL cholesterol (mg/dL)

125 ± 33

124,8 ± 32

127,2 ± 35,4

0,6

 < 55

2 (1.4)

0

2 (4.1)

 

 55–69

2 (1.4)

2 (2.2)

0

 

 70–99

25 (18)

16 (17)

9 (18)

 

 > 100

111 (79)

73 (80)

38 (78)

 

Non HDL cholesterol (mg/dL)

153 ± 35

153,6 ± 35

153 ± 39

0,9

Triglycerides (mg/dL)

140 ± 66

145,8 ± 71

131 ± 57

0,22

Apolipoprotein A1 (mg/dL)

140 ± 10

140 ± 9,4

142 ± 11

0,22

Apolipoprotein B (mg/dL)

102 ± 15

103 ± 14

102 ± 17

0,73

Apolipoprotein B48 (mg/dL)

9,8 ± 4,7

9,5 ± 4,7

10,4 ± 5

0,27

Apo E Genotype*

   

0,2

 - 2/2

1 (0,7)

9 (9,9)

1 (2,0)

 

 - 2/3

12 (8,6)

67 (73,6)

3 (6,1)

 

 - 3/3

100 (71,4)

13 (14,3)

33 (67,3)

 

 - 3/4

24 (17,1)

2 (2,2)

11 (22,4)

 

 - 4/4

2 (1,4)

   

 - 2/4

1 (0,7)

 

1 (2,0)

 

LIPC Genotype*

   

0,3

  (GG)

83 (59,3)

51 (56)

32 (65,3)

 

  (GA)

50 (35,7)

34 (37,4)

16 (32,7)

 

  (AA)

7 (5)

6 (6,6)

1 (2,0)

 
  1. Data are shown as mean ± SD or n(%)